mTOR ligands and polynucleotides encoding mTOR ligands
US9181314B2 · kind B2 · utility
1Cited by
9References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 25, 2015 |
| Grant date | Nov 10, 2015 |
| Priority date | — |
| Expiry date | Jun 25, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/41
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.